Suppr超能文献

多重蛋白质分析中的测量与质量控制问题:一个案例研究

Measurement and quality control issues in multiplex protein assays: a case study.

作者信息

Ellington Allison A, Kullo Iftikhar J, Bailey Kent R, Klee George G

机构信息

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.

出版信息

Clin Chem. 2009 Jun;55(6):1092-9. doi: 10.1373/clinchem.2008.120717. Epub 2009 Apr 16.

Abstract

BACKGROUND

Multiplex arrays are increasingly used for measuring protein biomarkers. Advantages of this approach include specimen conservation, limited sample handling, and decreased time and cost, but the challenges of optimizing assay format for each protein, selecting common dilution factors, and establishing robust quality control algorithms are substantial. Here, we use measurements of 15 protein biomarkers from a large study to illustrate processing, analytic, and quality control issues with multiplexed immunoassays.

METHODS

We contracted with ThermoScientific for duplicate measurements of 15 proteins in 2322 participants from a community-based cohort, a plasma control, and recombinant protein controls using 2 custom planar microarrays with 6 (panel A) or 9 (panel B) capture antibodies printed in each well. We selected constituent analytes in each panel based on endogenous concentrations and assay availability. Protocols were standardized for sample processing, storage, and freeze-thaw exposures. We analyzed data for effects of deviations from processing protocols, precision, and bias.

RESULTS

Measurements were within reportable ranges for each of the assays; however, concentrations for 7 of the 15 proteins were not centered on the dose-response curves. An additional freeze-thaw cycle and erroneous sample dilution for a subset of samples produced significantly different results. Measurements with large differences between duplicates were seen to cluster by analyte, plate, and participant. Conventional univariate quality control algorithms rejected many plates. Plate-specific medians of cohort and plasma control data significantly covaried, an observation important for development of alternative quality control algorithms.

CONCLUSIONS

Multiplex measurements present difficult challenges that require further analytical and statistical developments.

摘要

背景

多重阵列越来越多地用于测量蛋白质生物标志物。这种方法的优点包括样本保存、样本处理有限以及时间和成本降低,但为每种蛋白质优化检测形式、选择共同稀释因子以及建立稳健的质量控制算法面临诸多挑战。在此,我们利用一项大型研究中15种蛋白质生物标志物的测量结果来说明多重免疫测定中的处理、分析和质量控制问题。

方法

我们与赛默飞世尔科技公司签约,使用2种定制平面微阵列,对来自一个社区队列的2322名参与者、一份血浆对照和重组蛋白对照中的15种蛋白质进行重复测量,每种微阵列的每个孔中打印有6种(A组)或9种(B组)捕获抗体。我们根据内源性浓度和检测可用性在每个微阵列中选择组成分析物。对样本处理、储存和冻融暴露的方案进行了标准化。我们分析了数据,以了解偏离处理方案、精密度和偏差的影响。

结果

每种检测的测量值均在可报告范围内;然而,15种蛋白质中的7种蛋白质的浓度未集中在剂量反应曲线上。额外的冻融循环和一部分样本的错误样本稀释产生了显著不同的结果。重复测量之间差异较大的测量值按分析物、板和参与者聚类。传统的单变量质量控制算法拒绝了许多板。队列和血浆对照数据的板特异性中位数显著协变,这一观察结果对替代质量控制算法的开发很重要。

结论

多重测量带来了艰巨的挑战,需要进一步的分析和统计发展。

相似文献

1
Measurement and quality control issues in multiplex protein assays: a case study.
Clin Chem. 2009 Jun;55(6):1092-9. doi: 10.1373/clinchem.2008.120717. Epub 2009 Apr 16.
2
Antibody-based protein multiplex platforms: technical and operational challenges.
Clin Chem. 2010 Feb;56(2):186-93. doi: 10.1373/clinchem.2009.127514. Epub 2009 Dec 3.
3
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
6
Performance of multiplex cytokine assays in serum and saliva among community-dwelling postmenopausal women.
PLoS One. 2013;8(4):e59498. doi: 10.1371/journal.pone.0059498. Epub 2013 Apr 5.
7
Comparison of multiplex cytokine assays in a pediatric cohort with epilepsy.
Heliyon. 2021 Mar 12;7(3):e06445. doi: 10.1016/j.heliyon.2021.e06445. eCollection 2021 Mar.
8
Analytical performance of a commercial multiplex Luminex-based cytokine panel in the rat.
J Pharmacol Toxicol Methods. 2018 May-Jun;91:43-49. doi: 10.1016/j.vascn.2018.01.005. Epub 2018 Jan 31.
10

引用本文的文献

1
Benchmarking of a multi-biomarker low-volume panel for Alzheimer's disease and related dementia research.
Alzheimers Dement. 2025 Feb;21(2):e14413. doi: 10.1002/alz.14413. Epub 2024 Nov 22.
2
Advancing Microfluidic Immunity Testing Systems: New Trends for Microbial Pathogen Detection.
Molecules. 2024 Jul 15;29(14):3322. doi: 10.3390/molecules29143322.
3
Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation.
Clin Transl Immunology. 2023 Nov 28;12(12):e16815. doi: 10.1002/cti2.1473. eCollection 2023.
4
Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias.
Neurotherapeutics. 2023 Jul;20(4):955-974. doi: 10.1007/s13311-023-01370-8. Epub 2023 Jun 28.
5
Liquid chromatography-tandem mass spectrometry for clinical diagnostics.
Nat Rev Methods Primers. 2022;2(1):96. doi: 10.1038/s43586-022-00175-x. Epub 2022 Dec 8.
6
Molecular diagnostics in neurotrauma: Are there reliable biomarkers and effective methods for their detection?
Front Mol Biosci. 2022 Sep 29;9:1017916. doi: 10.3389/fmolb.2022.1017916. eCollection 2022.
10
Sequential Protein Capture in Multiplex Single Molecule Arrays: A Strategy for Eliminating Assay Cross-Reactivity.
Adv Healthc Mater. 2021 Feb;10(4):e2001111. doi: 10.1002/adhm.202001111. Epub 2020 Sep 6.

本文引用的文献

1
Protein microarray platforms for clinical proteomics.
Proteomics Clin Appl. 2007 Sep;1(9):934-52. doi: 10.1002/prca.200700154. Epub 2007 Aug 10.
2
Suspension microarrays for the identification of the response patterns in hyperinflammatory diseases.
Med Eng Phys. 2008 Oct;30(8):976-83. doi: 10.1016/j.medengphy.2008.01.003. Epub 2008 Mar 3.
3
Simultaneous detection of eight analytes in human serum by two commercially available platforms for multiplex cytokine analysis.
Clin Vaccine Immunol. 2008 Jan;15(1):42-8. doi: 10.1128/CVI.00211-07. Epub 2007 Nov 14.
5
6
Protein microarray platform for the multiplex analysis of biomarkers in human sera.
J Immunol Methods. 2006 Oct 20;316(1-2):1-7. doi: 10.1016/j.jim.2006.03.019. Epub 2006 Aug 23.
9
The External RNA Controls Consortium: a progress report.
Nat Methods. 2005 Oct;2(10):731-4. doi: 10.1038/nmeth1005-731.
10
Bias as a threat to the validity of cancer molecular-marker research.
Nat Rev Cancer. 2005 Feb;5(2):142-9. doi: 10.1038/nrc1550.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验